B. Randazzo

5.1k citations
72 papers · 3.9k · 2 hit papers · h-index 29

Impact in

  • Immunology top 0.5%
    • Psoriasis: Treatment and Pathogenesis
  • Dermatology top 0.2%
    • Dermatology and Skin Diseases

Papers in

    • Psoriasis: Treatment and Pathogenesis 29
    • Gastrointestinal motility and disorders 9
    • Gastroesophageal reflux and treatments 4

B. Randazzo

68 papers receiving 3.8k citations

B. Randazzo's Hit Papers

Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparator–controlled VOYAGE 2 trial 2017 · 546 citations
5460+3+6Years since publication200400600

Peers

B. Randazzo
Comparison fields: 5 of 93
  • Immunology 2.6k
  • Dermatology 1.0k
  • Hematology 388
  • Rheumatology 477
  • Gastroenterology 167
Replace Aroldo Rizzo with:
Aroldo Rizzo Italy
M. Viguier France
Koichiro Ohmura Japan
Vincent Ho Canada
Massimo Ghio Italy
Lisa T. Dooley United States
Shervin Assassi United States
Corinne Miceli‐Richard France
Martine Bagot France
M. Beylot‐Barry France
B. Randazzo relative to Aroldo Rizzo Italy Aroldo Rizzo's profile →
Citations per field
00.5×5.3×
Aroldo Rizzo · 1×
Citations per year

Countries citing papers authored by B. Randazzo

Since Specialization
Citations

This map shows the geographic impact of B. Randazzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Randazzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Randazzo more than expected).

Fields of papers citing papers by B. Randazzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Randazzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Randazzo. The network helps show where B. Randazzo may publish in the future.

Co-authors

The 25 scholars most cited alongside B. Randazzo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B. Randazzo Line = papers co-authored together B. Randazzo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial
Hit paper breakdown →
2017650
2
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparator–controlled VOYAGE 2 trial
Hit paper breakdown →
2017546
3 2019271
4 2017248
5 2015246
6 2015169
7 1983158
8 2016127
9 2011118
10
Therapy of experimental human brain tumors using a neuroattenuated herpes simplex virus mutant.
1995104
11 199597
12
Use of a "replication-restricted" herpes virus to treat experimental human malignant mesothelioma.
199796
13 201792
14 201888
15 201963
16 201755
17 201854
18 202053
19 201150
20 199748

About B. Randazzo

B. Randazzo is a scholar working on Immunology, Gastroenterology, Pediatrics, Perinatology and Child Health, Oncology and Epidemiology, having authored 72 papers that have together received 3.9k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (29 papers), Gastrointestinal motility and disorders (9 papers), Herpesvirus Infections and Treatments (7 papers), Pharmaceutical studies and practices (7 papers), Dermatology and Skin Diseases (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers), Virus-based gene therapy research (5 papers) and Gastroesophageal reflux and treatments (4 papers). The work is most often cited by research in Immunology (2.6k citations), Dermatology (1.0k citations), Hematology (388 citations), Rheumatology (477 citations) and Gastroenterology (167 citations). B. Randazzo has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Yasmine Wasfi, Shu Li, Yaung‐Kaung Shen, Andrew Blauvelt, Michael Song, Kristian Reich, C.E.M. Griffiths, Kenneth B. Gordon, Alexa B. Kimball and Kim Papp. Their work appears in journals such as Annals of the Rheumatic Diseases, Journal of the American Academy of Dermatology, British Journal of Dermatology, Journal of Pain and Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact